Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
pharm-analyt, leading
lab in PEG analysis
After having completed another method establishment for a Polyethylenglycol
(PEG) recently pharm-analyt continues to be a leading lab
in PEG analysis. Quantitative analysis has always been the main pillar for
pharm-analyt for over 3 decades of operation.
Starting 1986 with bioanalysis and HPLC-UV
nowadays GMP release analysis and HPLC-MS/MS are at the core of pharm-analyt's
activities.
Only 20 people being employed at pharm-analyt we
have kept our flexibility in order to solve analytical challenges and more
recently also consistently keep timelines.
Quantifying PEGylated substances has been a
specialty for more than a decade becoming a core competence in the last 2
years. At the moment pharm-analyt serves 4 different clients with quantitative
analysis of PEGs and has methods to determine altogether 6 current pegylated
substances in the range of 4 to 60 kDa.
pharm-analyt has covered PEG determination in
the biological matrices rat/human plasma/CSF and FDP/FC/BDS formulations,
always going in the direction of using stable labelled internal standards.
The most refined and up-to-date method has a
calibration range of 20 to 1,000 ng/mL for a more than 50 kDa PEG in plasma
with a calibration curve that is from an aesthetic perspective a straight line
really.
We are good at analysing various peptides,
mycotoxins and anthracyclines which makes us a valued provider for the
pharmaceutical industry especially in oncology/chemotherapy. However, amazement
you will only experience with the PEG analytical competence and metaknowledge
you will find at pharm-analyt.
Send us your quantitative analytical problem
with a PEG over, you will have a 95 % chance that we will have a solution
within short time.
pharm-analyt, leading
lab in PEG analysis
After having completed another method establishment for a Polyethylenglycol
(PEG) recently pharm-analyt continues to be a leading lab
in PEG analysis. Quantitative analysis has always been the main pillar for
pharm-analyt for over 3 decades of operation.
Starting 1986 with bioanalysis and HPLC-UV
nowadays GMP release analysis and HPLC-MS/MS are at the core of pharm-analyt's
activities.
Only 20 people being employed at pharm-analyt we
have kept our flexibility in order to solve analytical challenges and more
recently also consistently keep timelines.
Quantifying PEGylated substances has been a
specialty for more than a decade becoming a core competence in the last 2
years. At the moment pharm-analyt serves 4 different clients with quantitative
analysis of PEGs and has methods to determine altogether 6 current pegylated
substances in the range of 4 to 60 kDa.
pharm-analyt has covered PEG determination in
the biological matrices rat/human plasma/CSF and FDP/FC/BDS formulations,
always going in the direction of using stable labelled internal standards.
The most refined and up-to-date method has a
calibration range of 20 to 1,000 ng/mL for a more than 50 kDa PEG in plasma
with a calibration curve that is from an aesthetic perspective a straight line
really.
We are good at analysing various peptides,
mycotoxins and anthracyclines which makes us a valued provider for the
pharmaceutical industry especially in oncology/chemotherapy. However, amazement
you will only experience with the PEG analytical competence and metaknowledge
you will find at pharm-analyt.
Send us your quantitative analytical problem
with a PEG over, you will have a 95 % chance that we will have a solution
within short time.